First CTE diagnosis in living former NFL player confirmed, but questions remain

The first diagnosis in a living patient of the dementia type that’s been hitting one former NFL player after the next—chronic traumatic encephalopathy, or CTE—has been documented.

In a study published this week in Neurosurgery, researchers describe their work using PET with the radiotracer FDDNP to see the damaging tau proteins in vivo.

The study’s lead author, Bennet Omalu, MD, MPH, tells CNN that the affected player was Fred McNeill, who played linebacker for the Minnesota Vikings for 12 years.

McNeill retired in 1985, was diagnosed in 2012 and died in 2015. His CTE was confirmed by autopsy.

Covering the development for CNN, Sanjay Gupta, MD, notes that only 14 NFL players have been examined with FDDNP-PET, and only McNeill’s has been confirmed.

Gupta also points out that much research remains to be done.

“The question is, will the test be able to distinguish CTE from other dementias,” he says, “like Alzheimer’s?”

Get the rest:

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.